This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Finacea (Foam)

Bayer AG

Drug Names(s): 15% Azelaic Acid (AzA)

Description: Bayer also developed a separate formulation for Finacea (Gel).

Azelaic acid is an organic compound with the formula (CH2)7(CO2H)2. Azelaic acid is a naturally occurring molecule that can be found in barley and yeast as well as in the human body.

Deal Structure: Intendis and Foamix
In January 2014, Intendis and Foamix announced that they have executed a worldwide license agreement for a dermatological foam. The agreement was signed following successful completion of Foamix's development of a novel alcohol-free foam.

Under the terms of the agreement, Intendis is to pay Foamix a signing fee and milestone payments, as well as royalties based on net sales. Intendis is a wholly owned subsidiary of Bayer.

Partners: Foamix Pharmaceuticals Ltd.

Finacea (Foam) News

Pink Sheet Berlex Finacea

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug